Logo-aim
Arch Iran Med. 2024;27(2): 51-61. doi: 10.34172/aim.2024.10
PMID: 38619028        PMCID: PMC11017263

Original Article

Epidemiology and Prevalence of Dyslipidemia Among Adult Population of Tehran: The Tehran Cohort Study

Akbar Shafiee 1 ORCID, Sina Kazemian 1,2 ORCID, Arash Jalali 2,3 * ORCID, Farshid Alaeddini 1 ORCID, Soheil Saadat 4 ORCID, Farzad Masoudkabir 2 ORCID, Hamed Tavolinejad 1 ORCID, Ali Vasheghani-Farahani 2 ORCID, Vicente Artola Arita 5 ORCID, Saeed Sadeghian 1 ORCID, Mohamamdali Boroumand 1 ORCID, Abbasali Karimi 1 ORCID, Oscar H Franco 5 ORCID

Cited by CrossRef: 0

1- Cheraghian B, Saki N, Sarvandian S, Hashemi S, Hosseini S, Saki S, Rahimi Z. Evaluation of dyslipidemia based on ATP III guideline in adults in Southwest Iran: a population-based study. Sci Rep. 2025;15(1) [Crossref]
2- Kazemian S, Tabatabaei F, Azimi A, Akbarzade I, Hooshmand E. Awareness, Treatment, and Control of Hypertension Among Hypertensive Older Adults in Iran: A Cross‐Sectional Study From the Ardakan Cohort Study on Aging. Health Science Reports. 2025;8(12) [Crossref]
3- Motamed-Gorji N, Sepanlou S, Moallemian Isfahani M, Ahmadi A, Alipour M, Dehghan A, Ebrahimnejad P, Fattahi M, Goddusi Johari M, Jamali Z, Kaykhaei M, Khoshbou_Garebagh S, Mansour-Ghanaei F, Matin S, Mirzaei M, Moradi Y, Nejatizadeh A, Ostadrahimi A, Rastegar A, Sedaghattalab M, Shakiba E, Eghtesad S, Mohammadi Z, Poustchi H, Malekzadeh R, Shayo F. Epidemiology and determinants of dyslipidemia in Iranian population: Results from the PERSIAN cohort. PLoS One. 2026;21(7):e0352516 [Crossref]
4- Kubielas G, Lee C, Wleklik M, Czapla M, Surma S, Jakubiak G, Mysiak A, Lisiak M, Uchmanowicz I. Trends in cardiovascular risk factors in poland: results from the comprehensive cardiovascular risk prevention program. BMC Public Health. 2025;25(1) [Crossref]
5- Mossavarali S, Azizpour Y, Golestani A, Rezaei N, Khosravi S, Mirzad M, Khashayar P, Tabatabaei-Malazy O. Prevalence of dyslipidemia and its association with blood pressure control in Iranian hypertensive patients: insights from STEPS 2021. Lipids Health Dis. 2025;24(1) [Crossref]
6- Hosseini S, Takian A, Bakhtiari A, Ahmadi B, Amerzadeh M, Arani L. Introducing optimal performance scenario for an Urban Comprehensive Health Center affiliated with Primary Healthcare Network in Iran. 2025;5(1) [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.